Tift Leo

ZelosDx is a Tucson-based company that specializes in developing blood testing products to aid researchers in making significant breakthroughs in brain health and disease. Their innovative solution addresses the challenges faced in the field of neurologic disease and brain trauma, offering low-cost blood testing products that can be used as tools for research, drug development, and early diagnosis. By leveraging the discovery that phagocytic cells recruited to the brain can re-enter the bloodstream, ZelosDx has identified a novel source of brain-derived biomarkers in peripheral blood monocytes. This breakthrough technology allows for the detection of recent brain damage and active neurodegeneration, providing valuable insights into pathological changes in the brain. With their unique approach, ZelosDx aims to revolutionize the field and contribute to the advancement of effective treatments and improved patient outcomes.Generated from the website

Luceome Biotechnologies is an emerging biotechnology company based in Tucson, Arizona, specializing in the discovery and development of drugs targeting kinases. Their innovative assay technology enables efficient identification of drugs against kinases, facilitating drug discovery processes. With a focus on both cell-based and cell-free kinase assays, Luceome offers customizable kinase panels and services to evaluate compound selectivity and measure target engagement. Their expertise also extends to providing custom assay development for screening inhibitors in-house, tailored to meet specific profiling needs. Luceome Biotechnologies is committed to unraveling mysteries and enabling discoveries in the field of molecular cell science.Generated from the website

NuvOx Pharma is a clinical stage pharmaceutical company based in Tucson, Arizona, dedicated to reversing hypoxia, a condition where the body's cells lack sufficient oxygen, which is a significant factor in various life-threatening diseases. Their mission is to ensure patient safety and provide access to life-saving oxygen therapeutics. With a team of industry pioneers and scientists, NuvOx Pharma is focused on developing a first-in-class oxygen therapeutic drug that enhances the flow of oxygen from the lungs to the blood and from the blood to the tissues. Their consistent results, demonstrated through over 30 animal studies and Phase Ib II clinical trials in stroke and oncology, have shown both safety and evidence of efficacy, leading to their upcoming trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).Generated from the website